☆ 4.6 Editorial Material

NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown?

INFLAMMOPHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19

Souparnika H. Manjunath et al.

Summary: This review discusses the potential of prophylactic quercetin supplementation in managing the COVID-19 pandemic. Quercetin has various mechanisms, including inhibiting SARS-CoV-2 replication, antiviral activity, inhibiting inflammatory signals, and mitigating coagulation abnormalities, which may play an important role in COVID-19 patients.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2022)

添加到收藏夹

Article Anesthesiology

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Jonathan H. Chow et al.

Summary: A retrospective cohort study in multiple hospitals in the United States showed that aspirin use in COVID-19 patients may be associated with reduced risk of mechanical ventilation, ICU admission, and in-hospital mortality. Further studies are needed to confirm a causal relationship.

ANESTHESIA AND ANALGESIA (2021)

添加到收藏夹

Editorial Material Rheumatology

Going viral: misinformation in the time of COVID-19

[Anonymous]

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes

Mina T. Kelleni

Summary: This manuscript presents a novel theory for the pathogenesis of COVID-19 and suggests the early use of NSAIDs, including ibuprofen, as a safe and potentially preventative measure for COVID-19 complications. The author also advocates against routine use of glucocorticoids for COVID-19 patients, recommending their use only for those with late acute respiratory distress syndrome.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19

Amit S. Lokhande et al.

Summary: Nitazoxanide, a US-FDA approved anti-protozoal drug, shows promise in repurposing for COVID-19 therapy by potentially enhancing host immune responses and improving patient conditions. In vitro studies and approved clinical trials worldwide support the potential of nitazoxanide in combating COVID-19 pathogenesis.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Direct oral anticoagulant use and risk of severe COVID-19

B. Flam et al.

Summary: The study found that ongoing DOAC use was not associated with reducing the risk of severe COVID-19, suggesting that early outpatient DOAC initiation would not modify prognosis.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

Liyuan Cao et al.

Summary: Necrostatin-1 (Nec-1) is an inhibitor of necroptosis that has been shown to play an important role in various diseases and has the potential to provide protection in diseases such as COVID-19. Research findings indicate that Nec-1 can ameliorate disease development by inhibiting the necroptosis signaling pathway.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Apoptosis induced by SARS-CoV-2: can we target it?

Ahmed Donia et al.

Summary: Viruses can trigger increased apoptosis in host cells, which plays a complex role in antiviral immunity and may contribute to viral clearance or tissue damage in diseases. The induction of apoptosis is a key feature of SARS-CoV-2 infection, and there is a direct correlation between apoptosis rate and COVID-19 severity. Targeting virus-induced apoptosis could be a promising strategy in treating SARS-CoV-2 infections.

APOPTOSIS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Azithromycin inhibited oxidative stress and apoptosis of high glucose-induced podocytes by inhibiting STAT1 pathway

Yu Wei Xing et al.

Summary: The study showed that azithromycin has a therapeutic effect on diabetic nephropathy by inhibiting the STAT1 pathway, alleviating inflammation, oxidative stress, and apoptosis in podocytes induced by high glucose.

DRUG DEVELOPMENT RESEARCH (2021)

添加到收藏夹

Article Cell Biology

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients

Elizabeth A. Thompson et al.

Summary: The study identifies a unique population of T cells expressing increased VDAC1 in severe and recovered COVID-19 patients, associated with mitochondrial dysfunction and apoptosis. Additionally, specific metabolic phenotypes of myeloid-derived suppressor cells in COVID-19 patients can distinguish between severe and mild disease. These findings offer insight into dysfunctional immune response in COVID-19 patients and potential for developing personalized therapeutic approaches.

CELL REPORTS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates

Sajad Fakhri et al.

Summary: The complex pathogenic pathways of COVID-19 require urgent development of new therapies to address future epidemics. Research shows that the destructive pathways of COVID-19 share similar clinical symptoms with severe acute coronary syndrome. Revealing the exact pathogenic pathways and host factors can pave the way for combating COVID-19.

MOLECULES (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of anticoagulant therapy in COVID-19 patients

R. G. Tieleman et al.

Summary: Studies on the impact of anticoagulation therapy on outcomes in COVID-19 patients suggest that there is currently insufficient evidence to support the notion that therapeutic anticoagulation can improve patient prognosis. While two studies showed an association between anticoagulation and lower incidence of pulmonary embolism, most studies did not demonstrate a positive effect on other clinical outcomes, mainly due to low scientific quality of the studies.

NETHERLANDS HEART JOURNAL (2021)

添加到收藏夹

Article Immunology

The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis

Chia Siang Kow et al.

Summary: Meta-analysis found no difference in the risk of fatal course of COVID-19 between NSAID users and non-users, suggesting that NSAIDs can be used in patients when indicated during the COVID-19 pandemic.

INFLAMMOPHARMACOLOGY (2021)

添加到收藏夹

Letter Pharmacology & Pharmacy

Home therapy of COVID-19 at the earliest may greatly prevent hospitalization

Sergio Pandolfi et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy

Mina T. Kelleni

Summary: The study recommends using a novel combination of resveratrol and zinc for managing COVID-19, with potential as a monotherapy for mild cases and as an adjuvant therapy. Clinical trials are suggested to assess the efficacy of these combinations, which may also have therapeutic potential for other diseases beyond COVID-19.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

NSAIDs and COVID-19: A Systematic Review and Meta-analysis

Nicholas Moore et al.

Summary: Observational data indicates that the theoretical risks of NSAIDs or ibuprofen in SARS-CoV-2 infection are not confirmed, as exposure to NSAIDs or ibuprofen did not increase the risk of hospital admission, death, or severe outcomes in SARS-CoV-2-positive patients.

DRUG SAFETY (2021)

添加到收藏夹

Editorial Material Immunology

COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators

Mina T. Kelleni

Summary: This manuscript proposes a novel immunological reclassification of diseases like COVID-19 as acute onset immune dysrhythmia syndrome (n-AIDS) and suggests the use of immunomodulators to effectively manage these diseases. It also introduces the concept of para COVID syndrome to describe various immune-related complications.

IMMUNOLOGIC RESEARCH (2021)

添加到收藏夹

Letter Critical Care Medicine

Azithromycin for mild-to-moderate COVID-19

Jigar Patel et al.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients

F. A. Cadegiani et al.

Summary: The study found that nitazoxanide, ivermectin and hydroxychloroquine showed significant benefits in early-stage COVID-19 patients, reducing viral shedding, disease duration, and adverse outcomes like respiratory complications, hospitalization, mechanical ventilation, and deaths. The combination of early detection and pharmacological approaches in early-stage COVID-19 consistently provided overwhelming benefits to patients, thus eliminating the need for full placebo controlled trials.

NEW MICROBES AND NEW INFECTIONS (2021)

添加到收藏夹

Article Medicine, General & Internal

Nitazoxanide superiority to placebo to treat moderate COVID-19-A Pilot prove of concept randomized double-blind clinical trial

Vinicius Fontanesi Blum et al.

Summary: This study compared the clinical efficacy and inflammatory response of NTZ and placebo in patients with SARS-COV-2 infection. The results showed that NTZ was superior to placebo in alleviating symptoms, shortening hospital stay, and improving inflammatory responses.

ECLINICALMEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation

Erika Cione et al.

MOLECULES (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19

Ishan Paranjpe et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Editorial Material Immunology

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

Yujie Ren et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Crosstalk between endoplasmic reticulum stress and anti -viral activities: A novel therapeutic target for COVID-19

Aditi Banerjee et al.

LIFE SCIENCES (2020)

添加到收藏夹

Letter Pharmacology & Pharmacy

Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management

Mina T. Kelleni

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Article Infectious Diseases

Nitazoxanide against COVID-19 in three explorative scenarios

Jose Meneses Calderon et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2020)

添加到收藏夹

Article Immunology

ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror

Mina T. Kelleni

INFLAMMOPHARMACOLOGY (2020)

添加到收藏夹

Review Immunology

A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

Lucinda Smart et al.

INFLAMMOPHARMACOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation

Shufen Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study

Aylin Koseler et al.

IN VIVO (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets

Ana Kasirer-Friede et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

添加到收藏夹

Review Immunology

Caspases in Cell Death, Inflammation, and Disease

Nina Van Opdenbosch et al.

IMMUNITY (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use

Paul Gurbel et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oxicam-derived non-steroidal anti-inflammatory drugs suppress 1-methyl-4-phenyl pyridinium-induced cell death via repression of endoplasmic reticulum stress response and mitochondrial dysfunction in SH-SY5Y cells

Tomohiro Omura et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

添加到收藏夹

Article Pediatrics

Non-steroidal Anti-inflammatory Drugs in Newborns and Infants

Jacob V. Aranda et al.

PEDIATRIC CLINICS OF NORTH AMERICA (2017)

添加到收藏夹

Review Critical Care Medicine

Prevention or Treatment of Ards With Aspirin: A Review of Preclinical Models and Meta-Analysis of Clinical Studies

Bernardo Amisa Panka et al.

SHOCK (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors

Christina E. Smith et al.

CELL CHEMICAL BIOLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy

Timothy D. Warner et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis

Zhongde Ye et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)

添加到收藏夹

Review Immunology

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Charles N. Serhan et al.

NATURE REVIEWS IMMUNOLOGY (2008)

添加到收藏夹

Article Neurosciences

Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling

T Yamazaki et al.

NEUROPHARMACOLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.